Skip to main content

ScienceDex / Researcher record

Yang, Tianxin

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #8,857
  • R01 Holder
  • Long-Funded

NIH Funding · FY2023

$1.1M
Full award amounts, FY2023
2
Records listing this PI
#8,857
By linked amount among FY2023 PIs
2006
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2006$779,7904#7,126
2007$515,9812#14,059
2008$511,3322#13,747
2009$350,3051#23,942
2010$358,3001#24,014
2011$321,4631#24,299
2012$320,8241#24,726
2013$302,7601#25,055
2014$324,0751#24,127
2015$789,4192#9,104
2016$737,3882#10,213
2017$1,309,1473#4,897
2018$1,616,8123#3,879
2019$566,5731#17,327
2020$1,103,9812#2,458
2021$1,103,9812#8,214
2022$1,157,7822#8,120
2023$1,115,3522#8,857

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20064 records
  2. FY20072 records
  3. FY20082 records
  4. FY20091 record
  5. FY20101 record
  6. FY20111 record
  7. FY20121 record
  8. FY20131 record
  9. FY20141 record
  10. FY20152 records
  11. FY20162 records
  12. FY20173 records
  13. FY20183 records
  14. FY20191 record
  15. FY20202 records
  16. FY20212 records
  17. FY20222 records
  18. FY2023 · selected2 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Yang, Tianxin. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2027 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.

FY2023 award categories

  • Internal Medicine

FY2023 award records by amount

NIH award records listing Yang, Tianxin as a PI. Multi-PI records show the full award amount for context.

  • 5R01HL160020-02R01Contact PI
    Adipose-derived sPRR controls circadian rhythm of blood pressure through inhibition of renal NCC activity
    University of Utah · Internal Medicine (NIH department code)
    $586.6K
    award amount
  • 5R01DK104072-06R01Contact PI
    Cloning and characterization of PRR24 as a specific renin receptor critically involved in vasopressin signaling in the kidney
    University of Utah · Internal Medicine (NIH department code)
    $528.8K
    award amount

Award organization

Organizations that administered FY2023 awards listing Yang, Tianxin as a PI.

FY2023 award administered by University of Utah (UT).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2006
    First NIH Award
    University of Utah
  2. 2006
    $500K Cumulative Funding
  3. 2006
    Entered Top 50% Nationally
    Ranked #7126
  4. 2007
    $1M Cumulative Funding
  5. 2009
    $2M Cumulative Funding
  6. 2012
    R01 Grant Holder
  7. 2016
    $5M Cumulative Funding
  8. 2017
    Entered Top 25% Nationally
    Ranked #4897
  9. 2021
    $10M Cumulative Funding